CLEAR PROOF CLARIFYING CLEANSING GEL ACNE MEDICATION- salicylic acid gel 
Mary Kay Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Clear Proof Clarifying Cleansing Gel
Drug Facts

Active ingredient

Salicylic Acid (2% W/W)

Purpose

Acne Medication

Uses

Warnings

For external use only

When using this product

  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • avoid contact with the eyes

Stop use and ask a doctor if

irritation or sensitivity develops or increases

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Inactive ingredients

arctium lappa root extract, butylene glycol, citric acid, cocamidopropyl betaine, cystoseira amentacea/caespitosa branchycarpa extract, disodium EDTA, DMDM hydantoin, epilobium angustifolium flower/leaf/stem extract, ethylparaben, glycerin, methylparaben, phenoxyethanol, propylene glycol, propylparaben, sodium C14-16 olefin sulfonate, sodium chloride, triethanolamine, water

Principal Display Panel - 127 g carton

clearproof

clarifying cleansing gel

acne medication

2% salicylic acid

4.5 OZ. NET WT. / 127 g

Mary Kay

image of carton

CLEAR PROOF CLARIFYING CLEANSING GEL  ACNE MEDICATION
salicylic acid gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51531-1349
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID2 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
SODIUM C14-16 OLEFIN SULFONATE (UNII: O9W3D3YF5U)  
WATER (UNII: 059QF0KO0R)  
COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
TROLAMINE (UNII: 9O3K93S3TK)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
ETHYLPARABEN (UNII: 14255EXE39)  
DMDM HYDANTOIN (UNII: BYR0546TOW)  
ARCTIUM LAPPA ROOT (UNII: 597E9BI3Z3)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
GLYCERIN (UNII: PDC6A3C0OX)  
EPILOBIUM ANGUSTIFOLIUM FLOWERING TOP (UNII: 08H094218D)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:51531-1349-41 in 1 CARTON08/15/2013
1127 g in 1 TUBE; Type 0: Not a Combination Product
2NDC:51531-1349-128 g in 1 TUBE; Type 0: Not a Combination Product08/15/2013
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalM00608/15/2013
Labeler - Mary Kay Inc. (049994452)
Establishment
NameAddressID/FEIBusiness Operations
Port Jervis Laboratories Inc.001535103manufacture(51531-1349)
Establishment
NameAddressID/FEIBusiness Operations
Englewood Lab Inc.172198223pack(51531-1349)
Establishment
NameAddressID/FEIBusiness Operations
Mary Kay Inc.103978839manufacture(51531-1349)

Revised: 7/2023
Document Id: 013e39e5-b0d2-e359-e063-6294a90a0ef2
Set id: e06a0132-cd30-4cec-ba2e-d29a120dc17a
Version: 8
Effective Time: 20230724
 
Mary Kay Inc.